{fql. Table 1 Indications for Orthotopic Liver Transplantation. Number of Transplantations
|
|
- Geoffrey Glenn
- 5 years ago
- Views:
Transcription
1 {fql Experience in Orthtpic Liver Transplantatin Indicatins, results and future Prspects I. Penn, J. Crman, A. Gustafssn, C. G. Halgrimsn, C. W. Putnam, G. Schrter, C. G. Grth, T. E. Starzl Since the first liver transplantatin in man was perfrmed in Denver in March 1963, 162 such peratins have been perfrmed thrughut the wrld. Apprximately ne third f the patients have been treated at the University f Clrad Medical Center and the Denver Veterans Administratin Hspital. This reprt will discuss ur experience with the indicatins fr hepatic replacement, the results btained and the prspects fr future imprvement. Indicatins Replacement f the liver is indicated in patients with serius liver disease whse life expectancy can be measured in days r weeks r perhaps a few mnths. The reasns fr peratin in ur center are listed in Table 1. Frm the Departments f Surgery and Pediatrics, University f Clrad Schl f Medicine and the Veterans Administratin Hspital, Denver, Clrad. This wrk was supprted by research grants frm the Veterans Administratin, by grants RR-OOSl and RR frm the general clinical research centers prgram f the Divisin f Research Resuces, Natinal Institutes f Health, and by grants A/! , AI-AM-08898, AM , and HE f the United States Public Health Service. We have nt transplanted the liver fr metastatic malignancy, as has been attempted in ther centers, because f the strng pssibility f ther extrahepatic metastases. With the exceptin f ne case where the tumr was adherent t the pylrus which als required resectin, we have nt perfrmed transplants fr primary hepatic malignancies which have extended beynd the cnfines f the liver. Table 1 Indicatins fr Orthtpic Liver Transplantatin Disease Number f Transplantatins Biliary Atresia 26 Primary Hepatic Tumrs 13 Cirrhsis 9 Chrnic Agressive Hepatitis 5 Wilsn's Disease 2 lupid Hepatitis 1 Retransplantatin fr severe rejectin 4 Ttal 60 "One patient had an incidental hepatma. As ur experience has grwn we have becme prgressively mre disappinted with the results f transplantatin fr primary malignant disease f the liver as we shall indicate later. We nw rarely recmmend transplantatin fr this indicatin.
2 Experience in Orthtpic Liver Transplantatin Fig. 1 a The extremely rapid develpment f pulmnary metastases in a patient wh underwent liver replacement fr hepatma. A. The chest is clear six days after transplantatin. B. Twenty-nine days pst-perative. Tw metastases are visible in the lwer left lung field (arrws). C. Five days later the tumr depsits previusly seen have grwn in size (hrizntal arrws) and a third fcus is nw present in the right lbe (vertical arrw). D. Frty-fur days. Metastatic grwths are scattered thrughut the lungs (arrws). E. Seventy-fur days pstperative. F. Fur mnths after transplantatin. Transient dyspnea was first nticed a few days later. The patient died f pulmnary and hepatic insufficiency 143 days after peratin. R L p A B c D Fig. 1 b Destructin f the hepatic hmgraft by tumr recurrence, as demnstrated by serial technetium liver scans. A. 68 days - The scan appears nrmal. B. 94 days - The patient had becme jaundiced. Hepatmegaly is evident. C. 101 days - Multiple areas f pr istpe cncentratin are nw visible. D. 111 days - The prcess has cntinued its rapid prgressin. By the time f death the hmgraft was almst cmpletely replaced by tumr.
3 c Experience in Orthtpic Liver Transplantatin Results Lng term survival can be achieved after liver transplantatin. In experiments in dgs and pigs we have had many survive mere than a. year. One dg is still alive mre than 8 years after transplantatin. In ur first 42 patients, in whm a minimum fllwup f 12 mnths was available, 11 survived at least ne year (Table 2). Three f these recipients lived mre than 2 years. One patient, wh was the lngest survivr in the wrld, died 31,'2 years after transplantatin. Table 2 11 One-y ar Survivrs after Orthtpic Liver Transplantatin An example is the patient in Fig. 1a. He was a 15 year ld by frm whm a large hepatma was remved. N secndary depsits were apparent at the time f transplantatin. Twenty-nine days later pulmnary metastases appeared and subsequently became larger and mre numerus. Serial scans f the hmgraft als shwed prgressive replacement with tumr, Fig. lb. The patient died f pulmnary and hepatic insufficiency 143 days after transplantatin. At autpsy the lungs and the hmgraft shwed extensive invasin by tumr (Figs. Ic and 1d). 29 Alive 3, II - Ili6 t 25 /8 years Died ~ II - 1 t 3 1/2 years 12 Mnths Cancer' 12 Mnths - Serum hepatitis, liver failure ]4 Mnths - Cancer 15 Mnths - Cancer 15 Mnths - Rejectin, liver failure 20 Mnths - Disseminated ncardia infectin" 30 Mnths - Rejectin, liver failure 42 Mnths -? Rejectin, liver failure 'This patient actually died a few days shrt f ne year. "The hmgraft shwed severe chrnic aggressive hepatitis, just as in her previusly remved native liver. Fig. 1 c Lungs shwing multiple large metastases. At the present time 8 patients are alive at 1~, ,31 2,10,14,28, and 34 mnths pst-transplantatin respectively, Primary malignant tumrs f the liver. In ur early experience it was hped that hepatic replacement might be useful therapy fr primarv malignant tumrs f the liver. Hwever, as lng term survival was achieved it became bvius that metastases were a majr prblem. In 6 f 7 patients treated fr hepatma and fllwed frm 2 t 14 mnths after transplantatin metastases appeared in the lungs, brain and even in the hmgrafts. Fig, 1 d Invasin and nearly cmplete destructin f the liver hmgraft by recurrent hepatma. At autpsy almst all the transplanted hepatic tissue was replaced by tumr. (By permissin f W. B, Saunders C., 1969.)
4 30 This disheartening experience has been repeatedly seen in ther cases. The sle exceptin was in a child aged almst 4 years wh was perated upn fr severe cngenital biliary atresia. An incidental finding in the liver specimen was a hepatma abut 2 em in diameter. The patient has nw been fllwed fr clse t 21/2 years with n clinical, radilgic r serlgic (ufetprtein estimatins) evidence f recurrent tumr. Experience in Orthtpic liver Transplantatin It is pssible that slwer grwing tumrs, such as chlangicarcinmas may have a ;'etter prgnsis, but thus far we have nt treated any such cases. Hwever, we have had the pprtunity t treat ne patient with an unusual tumr which des nt cmmnly metastasize utside the liver, primarily because it usually kills thrugh extensive replacement f the hepatic parenchyma leading t liver failure, r by causing fatal hemrrhage. The tumr was a hemangiend- Rejectin Cnsls weight 8~5 kg Rejectin 52 year ld c! Cnsls Platelets (mm3) wac rmm~ Cycl Phsphamide [mg/day) Prednisne (mg/day) ALG Bilirubin (mg%) Prthrmbin time 60 (%normal) SGOT 300 ( I.u.) Trarlsplant Time in days Fig. 2 The early curse f a 52 year ld male wh had liver replacement as treatment fr a hemangiendthelisarcma. After transplantatin, there was a severe rejectin crisis. The prtracted thrmbcytpenia pstperatively is ften nted after liver transplantatin and is prbably due t thrmbcyte sequestratin in the hmgraft. A LG - hrse antilymphcyte glbulin; SGOT - serum glutamic xalacetic transaminase in internatinal units; and ARROW milligrams f methyl prednislne intravenusly. (By permissin f Surg. Gynec. Obstet. 133:981, 1971).
5 Experience in Orthtpic Liver Transplantatin thelisarcma. The patient's curse is illustrated in Fig. 2. At the time f transplantatin he was gravely ill with severe hepatic dysfunctin and a serum bilirubin f '*0 mgm Uill. Fllwing peratin there was initial gd functin f the hepatic hmgraft. The patient then successfully wea~hered a but f severe rejectin after which liver functin remained satisfactry fr apprximately 3 mnths when his cnditin deterirated and he died. At autpsy examinatin, there were numerus metastases in the lungs and the hmgraft itself was the seat f large tumr depsits. These varius experiences with hepatic malignancies have made us adpt a plicy f restricting liver transplantatin almst exclusively t patients with benign hepatic disease. Cngenital biliary atresia. Encuraging results have been btained in this grup f patients. Tw patients lived at least ne year after transplantatin, tw mre survived mre than tw years and a further patient fr 3'/2 years. His curse is illustrated in Fig. 3. Despite a very pr tissue match the patient had nly tw minr rejectin episdes in the early pstperative perid. Thereafter, he enjyed gd health and excellent liver functin till shrtly befre his death. A bipsy f the hmgraft at 914 days shwed almst nrmal liver architecture. Terminally the patient develped a febrile illness which led t massive hepatic necrsis and death. It is nt knwn fr certain whether this was caused by a virus infectin r was a manifestatin f late rejectin. 31 SGOT (I.u. ) Alkaline Phsphatase (I.U.) Serum Prtein ig/100ml) ttal- Albumin rglbulin.. Bilirubin (mg/100ml) ttal- cnjugated- --- Azathiprine (mg) Prednisne (mg) ALG OT19 4 y. (j 14.3~18. kg O~~==~~~~~~~~~~==~========== ~~~~~~--~------~~~==--~~~=== ~ ~... ~-,, :.. ~.. ~.~ , ~.~ ~.--:.. :.::::.. ~.~.: ~.~:::.~.-:.:.~".. ~-~... """"" Rejectin 0~~~8-~~~-L~~~--~~~==~--~==----~ dall ever" a twice a week PRE-QP I OrthtpiC Transplantatin Time in days, Time in mnths Fig.3 The early curse f a 4 year ld child wh survived fr 3 1 /t years after liver transplantatin perfrmed as treatment f cngenital biliary atresia. Nte the rejectin episdes at 1 mnth and 21!~ mnths, which were easily cntrlled. (By permissin f W. B. Saunders C ) /"
6 32 Experience in Orthtpic Liver T ransplanta tin Orthtpic Transplantatin OT ~ 30.0kg II Y.. d Alkalln', PhOSPhiltase (I.U.I Serum Prtein (g/lqoml) ttal- Albumin rglhljl1n Bilirllblrl ijnql Hi)ml, ttalcnjllqated ---_ AzathiPrine (mg) Prednisne (mgl PredniSOlne IVlg) ALG (3mll Time in days Time in weeks mnths Fig. 40J Pstperative curse f an 11 year ld recipient f a liver hmgraft fr cirrhsis secnjary t Wilsn's disease. A severe reject:n crisis beginning abut 3 weeks pst-transplantatin eventually reversed and hepatic functin has been essentially nrmal since the sixth pstperative mnth. The patient remains in gd health almst 3 years after peratin. Wi/SOIl'S disease. Our experience with liver tr.lnspiantatin has given us a better uncll'r.,t.lncling f this metablic disrder. The wnditin is believed t be caused by an en7.yme deficiency which causes disturbed cpper metablism leading t its extensive depsitin in the liver, basal ganglia, the l'iirneas (Kayser-Fleischer rings) and ther tissues. The main clinical manifestatins.lre severe cirrhsis, r neurlgic disturb.lnces r bth. Experience with liver transpljntatin suggests that the enzyme defkil'nry may be cmpensated fr by rer l ln I11, nt f the diseased liver with a Ill'.lli h v 'lne and that cpper metablism m.ly ll!' restred t nrmal. The results in ne slilh patient are illustrated in Fig. 4a. Th(' ".Itient was seriusly ill with advanced -tcxx)1 T := 400i ~~l I ~~j H' BIOPsy," ~= 0~1--~~~,-~~--~--~~~~~ Time In days pst-transplantatin Fig. 4 b There was massive urinary excretin f cpper fllowing transplantatin. This lasted 6 mnths. A secndary peak f cpper excretin ccurred in respnse t a 3-day test curse f penicillamine. (By permissin f Lancet 1:505,1971).
7 Experience in Orthtpic Liver Transplantatin cirrhsis. After transplantatin the hmgraft underwent the wrst rejectin crisis that we have ever bserved in any f ur liver transplant recipients. The bilirubin rse t almst 50 mgm % with assciated rises in the alkaline phsphatase. Frtunately, it was pssible t reverse the immunlgic reactin and the patient has enjyed ~irtually nrmal liver functin ever since. He is nearly 3 years pst-transplantatin and is attending schl. Large amunts f cpper were passed in the urine fr 6 mnths after peratin (Fig. 4b) and bipsies f the hmgraft at 6, 18 and 30 mnths shwed a nrmal cpper cncentratin within the rgan. Similar results were btained in the case f anther by aged 15 years, wh in additin t advanced cirrhsis had severe neurlgic symptms. He is nw mre than a year pst-transplantatin. One and a half mnths after the peratin he develped jaundice, and elevatins f the SCOT (Fig. 5) and the alkaline phsphatase. Simultan- 33 Australia Antigen (CF Titer) Bilirubin (mg%) Cycl Phsphamide (mg/day) Prednisne (mg/day) ALG ,000 10,000 5, Transplant weight 50~ 47 kg year ldd' Time in days Fig.5 Triple drug therapy with cyclphsphamide, prednisne and hrse antilymphcyte glbulin (ALG) in a patient wh underwent liver transplantatin fr Wilsn's disease. Rejectin has never been diagnsed pstperatively. The temprary deteriratin in hepatic functin in the secnd pstperative mnth was accmpanied by Australia antigenemia detected by the cmplement fixatin (CF) technique and cnsequently was thught t be a manifestatin f serum hepatitis. (By permissin f 5urg. Gynec. Obstet. 133: 981, 1971).
8 34 eusly his serum became psitive fr the Australia antigen. He was diagnsed as having serum hepatitis and immunsuppressive therapy was nt increased as wuld have been the case had rejectin been suspected. The abnrmal liver chemistries gradually returned t nrmal and the patient has remained in gd health. This case illustrates a vitally imprtant pint - that pst-perative elevatin f the bilirubin and alkaline phsphatase is nt synnymus with rejectin. In fact, they may als be caused by serum hepatitis as in this case, but b- Experience in Orthtpic liver Transplantatin structin f the extrahepatic bile ducts r hepattxicity f the immunsuppressive drugs may be respnsible as will be discussed later. It is imperative t establish the crrect diagnsis as each cnditin requires a different frm f treatment. Hepatitis. Hepatitis ccurs pst-transplantatin in mre than 20 % f ur renal hmgraft recipients. As illustrated by the last case it may als ccur in hepatic hmgraft patients wh are expsed t many risks including thse impsed by the much larger bld transfusins required in liver 1 j l ~ AG.. IEOP,. Titer :... HI CF '.. Titer,. ACA Titer..J SGOT --,.,.. (I.U),- I ~ li '000 f " Alcaline Phsphatase (B-L units), 0 " Bilirubin (mg%) " Tfal /... COnjUgdted---J ='=== L -=:::::~="""' Serum Prtein 4 - Ttal_, Albumin- - -,t----===::.::::=--p'=========::::::=======::::=======::::::===:. -~ _._ J'Glbulin i ~ Azathiprine i8 Prednisne (mg)..: "t i_... (mg) z......, f=predn islne ~=-:,,,!,:"" ~~amll ui:i;~~~w~ic~e~a~w~e~e~_:=~::::t:~3jn~c~eja!::w~e~e~kt:::::;~~:;= (lg.i.v.) 1'I... 1/7'1'0 ""'70 "~"04N7Qunft s ' t c 110 llo ALG OrthtpiC Transplantatin (8/9/70) Time In days t ~, II. Fig. 6 Orthtpic hepatic transplantatin fr liver failure caused by chrnic aggressive hepatitis. The Australia antigen which had been de tectable in multiple serum samples fr ne year befre peratin, disappeared within hurs after remval f the patient's wn liver. Hwever, the Australia antigen reappeared in her bld stream abut 2 mnths pst-transplantatin at a time when she develped a clinical episde f hepatitis.
9 Experience in Orthtpic Liver Transplantatin replacement. In view f these findings is there any hpe f treating lethal serum hepatitis with liver transplantatin? In the present state f ur knwledge it is nt pssible t give a definite answer t t!tis questin. We have n experience with hepatic replacement in the treatment f acute fulminating hepatitis, althugh it has been unsuccessfully attempted elsewhere. Hwever, we have perfrmed liver replacement in cases f hepatic failure caused by chrnic aggressive hepatitis, Australia antigen psitive. Fig. 6 shws the curse f a 28 year ld wman with this disrder. Her serum had been persistently psitive fr the Australia antigen fr 2 years. At the time f admissin t the hspital she was gravely ill with severe ascites, large pleural effusins, a serum albumin f less than 2 gm/ioo rnl and a prthrmbin time f less than 20 %. Fllwing transplantatin her serum prmptly became negative fr the Australia antigen and remained s fr apprximately 2 mnths when it again became psitive. Sn afterwards her liver chemistries became abnrmal and it was apparent that she again had hepatitis. Despite slwly deterirating liver functin she was restred t a useful life amng her family and friends fr 20 mnths, when she died f a disseminated ncardia infectin. At autpsy, there was recurrence f chrnic aggressive hepatitis. T ecjmical prblems affecting results. Orthtpic liver transplantatin is a difficult prcedure as mst f the patients have severe prtal hypertensin. Remval f the recipients wn liver is cmplicated by the presence f extensive venus cllaterals and by cagulatin defects. In previus publicatins we have mentined prblems with anatmic abnrmalities, cltting f vascular anastmses, phrenic nerve palsy and ther hazards. In this reprt we wish t cncentrate n a cmplicatin f biliary drainage which we have encuntered in 4 recently treated patients. Our usual technique f biliary recnstructin is by means f a chlecystdudenstmy after having ligated the cmmn bile duct distal t its junctin with the cystic duct (Fig. 7). This area is ptentially 3S ) // Fig. 7 Orthtpic liver transplantatin- ch~ lecystdudenstmy has been perfrmed fr biliary drainage. G. B. = gall bladder; H. A. = hepatic artery; 1. V. C. = inferir vena cava; P. V. = prtal vein. (By permissin f Ann. Surg. 168:392, 1968). vulnerable and may becme bstructed with inspissated bile r pssibly with cellular debris cast ff int the lumen in the curse f rejectin. In the 4 recent cases mentined abve biliary bstructin develped after an initial perid f nrmal bile drainage. Tw f the patients were perated upn in an attempt t relieve the bstructin which was cnfirmed by perative chlangigraphy (Fig. 8). Hwever, surgery was undertaken t late and the patients died f hepatic damage caused by the bstructin, cmplicated by ascending chlangitis. In the ther 2 patients the lesin was fund at autpsy examinatin. In each case the epithelial cells
10 30 Experience in Orthtpic Liver Transplantatin Chlecystdudenstmy B Fig. 8 Chlangigraphy f a hepatic hmgraft in which biliary recnstructin was with chlecystdudenstmy. LEFT - Technique f dye injectin thrugh a dudentmy and the anastmsis. RIGHT - Obstructed duct system. Despite re-explratin and cnversin t chledchdudenstmy, the recipient died f uncntrlled sepsis 46 days after transplantatin. f the bile ducts were swllen and cntained large numbers f cytmegalvirus inclusins, which were als present in the large accumulatins f intraluminal debris. It appears pssible that these bstructins were caused r at least cntributed t by cytmegalvirus infectin. In an attempt t avid this cmplicatin chledchdudenstmy was attempted in 4 subsequent cases using a new methd illustrated in Figs. 9a and 9b. Hwever in ne case the implanted bile duct retracted ut f the dudenum causing a fatal biliary peritnitis. We have since reverted t using chlecystdudenstmy. Future Prspects As experience has accumulated we have learned t avid many tedmical pitfalls which we encuntered in ur early cases. The biliary drainage prblems mentined abve have made us adpt a plicy f early explratin in any cases f prlnged pstperative jaundice, with chlangiography and, if necessary, biliary recnstructin. If warranted, antiviral therapy with cytsine arabinside will als be instituted. It is 'hped that these measures will imprve ur lng term results. Anther reasn fr hpe that we may imprve n ur 26 % ne year survival fig-
11 Experience in Orthtpic Liver Transplantatin ft' " k' A 5 ' ',~~('~ ~ --1.~~~-_ '.-... ;>::. ",C,''U,2de, nstmy." ~ I 37 \/W' ~) " 0 " i:.,' \ \ I; E'~ Fur sutures in place Fig. 9 a Technique f chledchdudenstmy. After pening the dudenum (A), a submucsal tunnel is created (8, C) thrugh which the hmgraft cmmn bile duct is passed (E). Fig. 9 b Chledchdudenstmy (cntinued). The hmgraft bile duct is secured in place with fur fine sutures (G, H, I) in such a way as t create an everting nipple (J). ure hinges n new develpments in immunsuppressin. Studies in renal hmgraft recipients during the past 15 mnths have shwn that Imuran can be effectively replaced as an immunsuppressive agent by small dses f cyclphsphamide, which d nt appear t be as hepattxic. Furthermre, a prly functining liver may fail t metablize Imuran prperly. Cyclphsphamide, n the ther hand, is given in its metablically active frm and shuld be effective n matter what the state f hepatic functin. In ur mst recent experience using cyclphsphamide in cmbinatin with prednisne and ALG, 4 f 5 liver re- cipients have dne well frm 1 t 4 mnths after peratin. If these preliminary encuraging findings are cnfirmed by further experience we may be n the threshld f a majr new advance in liver transplantatin. Summary The prime indicatin fr liver replacement is advanced benign hepatic disease. A ne-year survival rate is currently being achieved. A vidance f technical pitfalls and imprvements in immunsuppressive therapy may result in better lng term survival figures.
12 38 References: 1. Martineau, G., K. A. Prter, 7. Crman, B. Launis, G. T. Schrter, W. Palmer, C. W. Putnam, C. G. Grth, C. G. H algrimsn, I. Penn and T. E. Starz!: Delayed biliary duct bstructin after rthtpic liver transplantatin. Surgery 72, , Penn, 1. and T. E. Starzl: The clinical aspects f rthtpic liver transplantatin. In: Bilgy and Surgery f Tissue Transplantatin, ed. Andersn, J. M. Oxfrd, Blackwell Scientific Publicatins, 1970, p. 245 Experience in Orthtpic Liver Transplantatin 3. Penn, J., C. G. Halgrimsn and T. E. Starz!: Liver transplantatin in man. Ann. N. Y. Acad. Sci. 170; 251, Starzl, T. E. and C. W. Putnam: Experience in Hepatic Transplantatin. Philadelphia, Saunders, 1969 S. Starzl, T. E., C. W. Putnam, C. G. Halgrimsn, G. T. Schrter, G. Martzneau, B. Launis, 7. L. Crman, I. Penn, A. S. Bth 7r., C. G. Grth and K. A. Prter: Cyclphsphamide and whle rgan transplantatin in human beings. Surg. Gynec. Obstet. 133; 981, 191
THROUGH 1979, immunosuppressive
Five-Year Survival After Liver Transplantatin THROUGH 1979, immunsuppressive therapy fr liver transplantatin at ur center was with aathiprine (r cyclphsphamide) and sterids, t which antilymphcyte glublin
More informationMetabolic Effects of Hepatic Replacement in Wilson's Disease
Metablic Effects f Hepatic Replacement in Wilsn's Disease By Carl G. Grth, Reuben S. Dubis, Jacques Crman, Ake Gustafssn, Shunzabur watsuki, Denis O. Rdgersn, Charles G. Halgrimsn, and Thmas E. Starzl
More information<J. OJ 'I. Cyclophosphamide for Clinical Renal and Hepatic Transplantation
OJ 'I U (fl
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationTRANSPLANTATION AND CLINICAL IMMUNOLOGY. Proceedings of the Twenty-Second International Course, Lyon, May 1990
-----.---.----~ Reprinted frm: TRANSPLANTATION AND CLINICAL IMMUNOLOGY VOLUME XXII Multiple Transplants Prceedings f the Twenty-Secnd Internatinal Curse, Lyn, 2-23 May 99 This publicatin was made pssible
More informationCYCLOPHOSPHAMIDE AND WHOLE ORGAN TRANSPLANTATION IN HUMAN BEINGS
CYCLOPHOSPHAMIDE AND WHOLE ORGAN ATION IN HUMAN BEINGS T. E. ST ARZL, M.D., F.A.C.S., C. W. PUTNAM, M.D., C. G. HALGRIMSON, M.D., G. T. SCHROTER, M.D., G. MARTINEAU, M.D., B. LAUNOIS, M.D., J. L. CORMAN,
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More informationA Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.
SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationVaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE
Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationNeonatal Jaundice Guideline
Nenatal Jaundice Guideline Guideline Number: 663 Supersedes: Classificatin Clinical Versin N: Date f EqIA: Apprved by: Date Apprved: Date made active: Review Date: 1 Obstetric Written Dcumentatin Review
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationWARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES
INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationWhat Should One Know About Thalassaemia Minor
What Shuld One Knw Abut Thalassaemia Minr What Is Thalassaemia? Thalassaemia is a cmmn inherited genetic disrder f hemglbin (Hb). T understand Thalassaemia ne shuld knw a bit mre abut Hb and its Structure
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationTREATMENT OF POLYCYTHEMIA VERA
RUSSELL L. HADEN, M.D. Plycythemia vera is characterized by an increase in the number f red bld cells. This disease is insidius in rigin, chrnic, and withut pathgnmnic symptms r physical findings. Early
More informationPercutaneous Nephrolithotomy (PCNL)
Percutaneus Nephrlithtmy (PCNL) What is a percutaneus nephrlithtmy? is the mst effective f the cmmnly perfrmed prcedures fr kidney stnes. It is the best prcedure fr large and cmplex stnes. T perfrm this
More informationInfluenza (Flu) Fact Sheet
Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder
More informationALLERGY. The effect of alternate-day prednisone on the white blood count in children with chronic asthma
The Jurnal f ALLERGY and CLINICAL IMMUNOLOGY VOLUME 51 NUMBER 2 The effect f alternate-day prednisne n the white bld cunt in children with chrnic asthma H. Cha, M.D., and A. Gilbert, M.T. Denver, Cl. Children
More informationAnnex III. Amendments to relevant sections of the Product Information
Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationGlaucoma Interviews: Due Tuesday, May 22 nd
Glaucma Interviews: Due Tuesday, May 22 nd 1) Read the glaucma article well! It will explain what it is, plus tell yu sme symptms and risk factrs. Yu may want t use a highlighter r pen t mark imprtant
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationM.R.C.Path. causes to the raised plasma urea in patients admitted
Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More informationInternational Myeloma Working Group Guidelines on Imaging Techniques in the Diagnosis and Monitoring of Multiple Myeloma 1
Internatinal Myelma Wrking Grup Guidelines n Imaging Techniques in the Diagnsis and Mnitring f Multiple Myelma 1 Up t 90% f myelma patients develp stelytic lesins, a majr cause f mrbidity and mrtality,
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationPET FORM Planning and Evaluation Tracking ( Assessment Period)
Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationDonating a Kidney for Transplantation. Living Kidney Donation Patient Education
Dnating a Kidney fr Transplantatin Living Kidney Dnatin Patient Educatin Dnating a Kidney fr Transplantatin Indiana University Health has a lng histry in the field f transplantatin, and cnsistently ranks
More informationCampus Climate Survey
Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed
More informationBefore Your Visit: Mohs Skin Cancer Surgery
Befre Yur Visit: Mhs Skin Cancer Surgery Yur Kaiser Permanente Care Instructins Skin Cancer Infrmatin What is skin cancer? Skin cancers are tumrs, r malignancies, f the skin. Skin cancer is assciated with
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject
More informationReference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57
Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical
More informationWidening of funding restrictions for rituximab and eltrombopag
20 February 2014 Widening f funding restrictins fr rituximab and eltrmbpag PHARMAC is pleased t annunce the apprval f prpsals t widen the restrictin n rituximab use in DHB hspitals and expand the funding
More informationPackage leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate
Package leaflet: Infrmatin fr the user Daceptn 5 mg/ml Slutin fr infusin Apmrphine hydrchlride hemihydrate Read all f this leaflet carefully befre yu start using this medicine because it cntains imprtant
More informationSTUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM
Published Online: 1 June, 1936 Supp Inf: http://di.rg/1.184/jem.63.6.83 Dwnladed frm jem.rupress.rg n August 13, 218 STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM BY T. P. MAGILL,
More informationCONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS
CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,
More informationDr. Tozzi s and Dr. Roehrig s Patient Guide to Total Hip Replacement
Dr. Tzzi s and Dr. Rehrig s Patient Guide t Ttal Hip Replacement This guide is meant t help yu better understand yur upcming hip surgery. It is generalized infrmatin, and individual patients have unique,
More informationNeurological outcome from conservative or surgical treatment of cervical spinal cord injured patients
1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationMitosis and Meiosis Lecture Notes
Bilgy Mitsis and Meisis Lecture Ntes Name Per Learning Gals Quiz #6: December 6th Describe what happens during interphase Identify steps f mitsis/meisis by picture and functin Explain the diseases that
More informationPodcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10
Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationREPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE
REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN February 12, 2018 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap): XVIVO HIGHLIGHTS
More informationPackage leaflet: Information for the user. Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Solution for injection dalteparin sodium
Package leaflet: Infrmatin fr the user Fragmin 10,000 IU/1 ml and 10,000 IU/4 ml Slutin fr injectin dalteparin sdium Read all f this leaflet carefully befre yu start using this medicine because it cntains
More informationVaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE
Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están
More informationRequest for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax
Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus
More informationUpdate on Concussions in Soccer
Update n Cncussins in Sccer Ricard E. Clberg, M.D., RMSK Andrews Sprts Medicine & Orthpedic Center American Sprts Medicine Institute Hw many here have had a cncussin? Definitins Signs & symptms Management
More informationDiphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Polio-Haemophilus Influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib-HB)
Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Pli-Haemphilus Influenzae type b Cnjugate Cmbined Vaccine Bilgical Page (DTaP-IPV-Hib-HB) Sectin 7: Bilgical Prduct Infrmatin Standard #: 07.214 Created
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationFor our protection, we require verification that you have received this notice. Therefore, please sign below.
PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults
More informationHead and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.
DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that
More informationAdult Preventive Care Guidelines
Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether
More informationChapter 6: Impact Indicators
Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationBenefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria
Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health
More informationName: Date: Period: Notes: The Blood and Lymphatic System
Name: Date: Perid: Cmpsitin f Bld and their Functins Red Bld Cells (aka ) Structure Ntes: The Bld and Lymphatic System D nt have a like ther cells d Cntain a specialized prtein called Hemglbin cntains
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationMethadone Maintenance Treatment for Opioid Dependence
POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin
More informationUse of OKT3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection 1
101 Nephrn Editrs: G.M. Berlyne, Brklyn, N.Y.; S. Givannetti, Pisa Reprint Publisher: S. Karger AG. Basel Printed in Switzerland Transplantatin Therapeutics: Mnclnal Antibdy Sympsium and Wrkshp, Miami,
More informationAdhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy*
FERTILITY AND STERILITY Cpyright 99 The American Fertility Sciety Vl., N., May 99 Printed n acid-free paper in U.S.A. Adhesin frmatin after laparscpic surgery in tubal pregnancy: a randmized trial versus
More informationWHAT IS YOUR DIAGNOSIS?
WHAT IS YOUR DIAGNOSIS? A 10 year ld female neutered Brder Cllie was presented t the R(D)SVS Canine Medicine Service fr investigatin f lethargy, inappetance and weight lss. She had been inappetant fr apprximately
More informationCDC Influenza Division Key Points November 7, 2014
In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates
More informationAdvantage EAP Employee Assistance Program
Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse
More informationCRANIOFACIAL RESECTION
CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationMEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP
MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride
More informationGeneric Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations
Dear Clleague Generic Immunsuppressants in the Specialist Area f Transplantatin Cnsensus n Implicatins and Practical Recmmendatins Executive Summary Slid-rgan transplants are the best pssible treatment
More informationLecture 9 PCL201 Drug Distribution
Lecture 9 PCL201 Drug Distributin Where d drugs distribute? Drug distributin (and ptentially cncentratin) will depend n bld flw and the physichemical prperties f the chemical Lipid and water slubility
More informationScreening Questions to Ask Patients
Screening Questins t Ask Patients 1. Have yu ever had TB (Tuberculsis)? Yes N 2. Have yu been living with anyne in the past tw years that has been diagnsed with TB? Yes N 3. Have yu ever had a Persistent
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More information* CORRESPO~~ING AUTHOR. YAWS/PMVH/jtf-88 IN CENTRAL AFRICA IMMUNOFLUORESCENCE FOR DIAGNOSIS GONZALEZ. MARTIN. M.H. GEORGES-COURBOT M.C. PALISSON. M.J.
YAWS/PMVH/jtf-88 YA~S IN CENTRAL AFRICA CLINICAL ASPECTS AND USEFULNESS OF INDIRECT ABSORBED IMMUNOFLUORESCENCE FOR DIAGNOSIS MARTIN. P.M.V.* GONZALEZ. J.P. MARTIN. M.H. GEORGES-COURBOT M.C. PALISSON.
More informationAnterior Total Hip Arthroplasty Patient Guide & Common Questions
Intrductin: Anterir Ttal Hip Arthrplasty Patient Guide & Cmmn Questins This handut is a general guide t cmmn indicatins fr anterir ttal hip arthrplasty, what t expect when underging the prcedure, risks,
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More informationΕπείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα
Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is
More informationITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.
Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet
More informationHow to become an AME Online
Hw t becme an AME Online 1. Check that yu meet the minimum technical requirements in rder t use the AME Online system: Operating System: Windws Vista (Service Pack 2) Windws 7 Windws 8, 8.1 Windws 10 Please
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated
More informationIndividual Assessments for Couples Treatment with HFCA
Individual Assessments fr Cuples Treatment with HFCA Jennifer S. Ripley, Ph.D. Many appraches t cuples therapy include an individual assessment whenever a cuple cmes fr treatment. Therapists shuld be aware
More informationΥποτροπιάζουσες Περικαρδίτιδες: Τι νεότερο; Γεώργιος Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.
Υποτροπιάζουσες Περικαρδίτιδες: Τι νεότερο; Γεώργιος Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν. Αθηνών Recurrent pericarditis after an initial episde f pericarditis ranges
More information